Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-04

Clinical Trial Update: Oxytocin and Approach-avoid in Grief [NA]

View source ↗

Summary

A completed clinical trial evaluating oxytocin’s effect on approach-avoidance behavior in individuals with Prolonged Grief Disorder and bereavement, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of Arizona | Conditions: Prolonged Grief Disorder, Bereavement | NA | Status: COMPLETED | Results posted: 2025-03-04